PQ 360
360. Deputy Billy Kelleher asked the Minister for Health the status of the drug ocrelizumab for the treatment of multiple sclerosis; if the drug is being assessed by the National Centre for Pharmacoeconomics, NCPE; and if not, if it will be assessed in the near future. [41461/17]
Introduced
3 October 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
3 October 2017
Summary
360. Deputy Billy Kelleher asked the Minister for Health the status of the drug ocrelizumab for the treatment of multiple sclerosis; if the drug is being assessed by the National Centre for Pharmacoeconomics, NCPE; and if not, if it will be assessed in the near future. [41461/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 3 October 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-10-03/360/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-10-03/pq_360